SHANGHAI, June 12, 2026 /PRNewswire/ -- On May 29, 2026, Pacific Time, Simcere Pharmaceutical Group Limited (2096.HK) entered into a research collaboration agreement with Stanford Medicine to jointly advance an exploratory study in the respiratory field, with the aim of developing...
Hence then, the article about simcere pharmaceutical enters into a research collaboration agreement with stanford medicine to develop innovative therapies for patients with idiopathic pulmonary fibrosis was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Simcere Pharmaceutical Enters into a Research Collaboration Agreement with Stanford Medicine to Develop Innovative Therapies for Patients with Idiopathic Pulmonary Fibrosis )
Also on site :
- Greg Evigan Shares Sweet ‘My Two Dads’ Throwback With Paul Reiser and Staci Keanan: ‘I Adore These 2 People!’
- Carole King Wrote ‘Will You Love Me Tomorrow’ at 18 and It Became the First No. 1 Song by Any Girl Group; She Sang It 11 Years Later on Tapestry
- Aaron Sorkin Says Jeremy Strong Treated His Co-Stars ‘The Way He Imagines’ Mark Zuckerberg Treats People While Shooting ‘The Social Reckoning’